Design and Structural Optimization of Orally Bioavailable RSK4 Inhibitors for the Treatment of Esophageal Squamous Cell Carcinoma
1. 系统已在2025-12-25 11:30:10对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1021/acs.jmedchem.5c02575
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c02575
其他信息:
出版社: American Chemical Society (ACS)
作者: Limin Leng; Shuai He; Manzhan Zhang; Yanru Yang; Yuanyuan Ge; Yuan Yuan; Qiqi Niu; Xiayu Shi; Zhuo Chen; Zhenjiang Zhao; Huan He; Honglin Li; Yufang Xu; Zhe Wang; Shiliang Li

